Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavino Casu

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 29, 2017
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: indications, patient selection, staff skills, organisation, and trainingGavino Casu, Michele Massimo Gulizia, Giulio Molon, et al.
Giornale Italiano Di Cardiologia (2006)|August 30, 2016
[ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: Percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: indications, patient selection, competences, organization, and operator training]Gavino Casu, Michele Massimo Gulizia, Giulio Molon, et al.
Vascular Pharmacology|September 12, 2024
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensusGiovanna Manzi, Raymond L Benza, Paola Argiento, et al.
American Journal of Respiratory and Critical Care Medicine|August 29, 2020
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial HypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
Journal of Nephrology|June 15, 2020
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysisSimonetta Genovesi, Luca Porcu, Giorgio Slaviero, et al.
Cardiology Journal|January 8, 2025
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpointJacek Kubica, Piotr Adamski, Robert Gajda, et al.
Minerva Cardiology and Angiology|March 11, 2021
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH SOLUTION): proposal of a study protocol aimed to realize a validated risk score for early diagnosisCristiano Miotti, Andrea M D'Armini, Beatrice Scardovi, et al.
European Heart Journal. Acute Cardiovascular Care|August 14, 2021
Device-related complications after Impella mechanical circulatory support implantation: an IMP-IT observational multicentre registry substudyMarco B Ancona, Matteo Montorfano, Giulia Masiero, et al.
ERJ Open Research|November 16, 2022
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
Giornale Italiano Di Cardiologia (2006)|March 24, 2020
[Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts]Maddalena Lettino, Alberto Zambon, Giuseppe Musumeci, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 29, 2017
ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: indications, patient selection, staff skills, organisation, and trainingGavino Casu, Michele Massimo Gulizia, Giulio Molon, et al.
Giornale Italiano Di Cardiologia (2006)|August 30, 2016
[ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: Percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: indications, patient selection, competences, organization, and operator training]Gavino Casu, Michele Massimo Gulizia, Giulio Molon, et al.
Vascular Pharmacology|September 12, 2024
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensusGiovanna Manzi, Raymond L Benza, Paola Argiento, et al.
American Journal of Respiratory and Critical Care Medicine|August 29, 2020
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial HypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
Journal of Nephrology|June 15, 2020
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysisSimonetta Genovesi, Luca Porcu, Giorgio Slaviero, et al.
Cardiology Journal|January 8, 2025
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpointJacek Kubica, Piotr Adamski, Robert Gajda, et al.
Minerva Cardiology and Angiology|March 11, 2021
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH SOLUTION): proposal of a study protocol aimed to realize a validated risk score for early diagnosisCristiano Miotti, Andrea M D'Armini, Beatrice Scardovi, et al.
European Heart Journal. Acute Cardiovascular Care|August 14, 2021
Device-related complications after Impella mechanical circulatory support implantation: an IMP-IT observational multicentre registry substudyMarco B Ancona, Matteo Montorfano, Giulia Masiero, et al.
ERJ Open Research|November 16, 2022
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertensionRoberto Badagliacca, Michele D'Alto, Stefano Ghio, et al.
Giornale Italiano Di Cardiologia (2006)|March 24, 2020
[Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts]Maddalena Lettino, Alberto Zambon, Giuseppe Musumeci, et al.
Pageof 11